Biosketch / Results /

Joan Merrill

Adjunct Assistant Professor, Department of Medicine

Contact Info

Joan.Merrill@nyumc.org


Anifrolumab, an Anti-Interferon-alpha Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Furie, Richard; Khamashta, Munther; Merrill, Joan T; Werth, Victoria P; Kalunian, Kenneth; Brohawn, Philip; Illei, Gabor G; Drappa, Jorn; Wang, Liangwei; Yoo, Stephen. Anifrolumab, an Anti-Interferon-alpha Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis & rheumatology. 2017 Feb;69(2):376-386 (2423962)

Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Khamashta, Munther; Merrill, Joan T; Werth, Victoria P; Furie, Richard; Kalunian, Kenneth; Illei, Gabor G; Drappa, Jorn; Wang, Liangwei; Greth, Warren. Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases. 2016 Nov;75(11):1909-1916 (2278742)

Economic evaluation of damage accrual in an international SLE inception cohort
Barber, M; Bruce, I N; Urowitz, M; Hanly, J G; Su, L; Romero-Diaz, J; Gordon, C; Bae, S -C; Bernatsky, S; Wallace, D J; Merrill, J T; Isenberg, D A; Rahman, A; Ginzler, E M; Petri, M; Dooley, M A; Fortin, P R; Gladman, D D; Sanchez-Guerrero, J; Steinsson, K; Ramsey-Goldman, R; Khamashta, M; Aranow, C; Alarcon, G S; Fessler, B J; Manzi, S; Nived, O; Jonsen, A; Zoma, A; Van, Vollenhoven R F; Ramos-Casals, M; Ruiz-Irastorza, G; Lim, S S; Kalunian, K C; Inanc, M; Kamen, D L; Peschken, C A; Jacobsen, S; Askanase, A; Buyon, J P; Theriault, C; Farewell, V; Clarke, A E. Economic evaluation of damage accrual in an international SLE inception cohort [Meeting Abstract]. Arthritis & rheumatology. 2016 October;Conference:(American):4235-4237 (2397772)

Longitudinal patterns in SLE response to standard of care therapy: Implications for SLE clinical trial design
Kim, M; Merrill, J T; Kalunian, K; Hahn, B H; Roach, A; Izmirly, P M. Longitudinal patterns in SLE response to standard of care therapy: Implications for SLE clinical trial design [Meeting Abstract]. Arthritis & rheumatology. 2016 October;Conference:(American):1382-1383 (2398012)

Changes in Antiphospholipid Antibody Titers during Pregnancy: Data from the PROMISSE Study
Yelnik, Cecile M; Porter, T Flint; Branch, D Ware; Laskin, Carl A; Merrill, Joan T; Guerra, Marta M; Lockshin, Michael D; Buyon, Jill P; Petri, Michelle; Sammaritano, Lisa R; Stephenson, Mary D; Kim, Mimi Y; Salmon, Jane E. Changes in Antiphospholipid Antibody Titers during Pregnancy: Data from the PROMISSE Study. Arthritis & rheumatology. 2016 Aug;68(8):1964-1969 (2032142)